Pathway Capital Management, LP
- SEC CIK
- 0001037353
- Latest filing
- Aug 3, 2026
DAWN holding history
Day One Biopharmaceuticals, Inc. in every 13F filed by Pathway Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DAWN overviewAll 13F holders of DAWNFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −995,686−100.0% | Sold out | Holders |
| Q4 2022 | 995,686 | $21.4M | 38.2% | +592,559+147.0% | Added | Holders |
| Q3 2022 | 403,127 | $8.07M | 25.9% | +403,127 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −242,245−100.0% | Sold out | Holders |
| Q4 2021 | 242,245 | $4.08M | 19.6% | +242,245 | New | Holders |